FDA Grand Rounds - Forensic Proteomics Applied to FDA Regulated Products
U.S. Food and Drug Administration Grand Rounds / National Forensic Chemistry Center presentation · February 5, 2026
Dr. David Skelton of the FDA National Forensic Chemistry Center outlined LC‑MS proteomic techniques used to identify and characterize peptides and proteins in FDA‑regulated products, and presented case studies including identification of semaglutide in an unknown powder, detection of collagen contamination, and a single‑amino‑acid substitution found in a suspect biotherapeutic (date not specified in transcript).
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.